🇺🇸 Doxycline in United States
115 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 115
Most-reported reactions
- Fatigue — 14 reports (12.17%)
- Diarrhoea — 13 reports (11.3%)
- Pneumonia — 13 reports (11.3%)
- Headache — 12 reports (10.43%)
- Pain — 12 reports (10.43%)
- Nausea — 11 reports (9.57%)
- Acute Kidney Injury — 10 reports (8.7%)
- Depression — 10 reports (8.7%)
- Drug Ineffective — 10 reports (8.7%)
- Dyspnoea — 10 reports (8.7%)
Other Other approved in United States
Frequently asked questions
Is Doxycline approved in United States?
Doxycline does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Doxycline in United States?
Hoffmann-La Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.